JUNO Therapeutics is a biotech organization with a vision of growing an independent operation to revolutionize the field of immunotherapy and medical treatment. To support the company's operational strategy and to establish a world-class headquarters and research facility, JUNO executed a lease for approximately 142,000-SF of space within the new 400 Dexter Project. The Juno Headquarters Project will provide a long-term headquarters building that fits JUNO's current needs and has the flexibility to accommodate future growth. The project incorporates laboratory space, office and conference uses. Floors will promote open communication and collaboration and continue to inspire the development of breakthrough science while promoting employee recruitment and retention.